StonvexLoading…
StonvexStonvexStonvexCore line items from IBM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $67.53B | $62.75B | $61.86B | $60.53B |
Operating Income | $10.33B | $5.80B | $8.69B | $1.16B |
Net Income | $10.59B | $6.02B | $7.50B | $1.64B |
EPS (Diluted) | $11.17 | $6.43 | $8.14 | $1.80 |
Total Assets | $151.88B | $137.18B | $135.24B | $127.24B |
Total Liabilities | $119.14B | $109.78B | $112.63B | $105.22B |
Cash & Equivalents | $13.59B | $13.95B | $13.07B | $7.89B |
Free Cash Flow OCF − CapEx | $12.10B | $12.40B | $12.69B | $9.09B |
Shares Outstanding | 936.95M | 926.29M | 915.01M | 906.09M |